Nasopharyngeal carcinoma targeted magnetic resonance contrast agent and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CENT SOUTH UNIV
- Publication Date
- 2013-03-27
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medical biomaterials, especially a kind of LMP1 + - Nasopharyngeal carcinoma targeting magnetic resonance contrast agent and preparation method thereof. Background technique
[0002] Tumor is one of the major diseases affecting human health today. A report by the World Health Organization shows that with the changes in the global human living environment, the incidence of global malignant tumors will increase from the current 10 million people / year to 15 million people / year. has become the number one killer threatening human health. In my country (especially South China), the incidence of nasopharyngeal carcinoma has been on the rise in recent years, and 80% of nasopharyngeal carcinoma cases in the world occur in China.
[0003] The pathological type of nasopharyngeal carcinoma is mainly non-keratinizing undifferentiated carcinoma, which is prone to cervical lymph nodes and distant metastasis; in the first course...